Conferences
IBCN 2024: Correlation of ctDNA Dynamics with Clinical Response in MIBC Patients Undergoing Trimodality Therapy
September 20, 2024
IBCN 2024: Dynamic Monitoring of Circulating Tumor DNA to Predict Prognosis in Muscle-Invasive Bladder Cancer Patients After Radical Cystectomy
September 20, 2024
IBCN 2024: Undetectable ctDNA Status Before Radical Cystectomy Predicts Improved Outcomes
September 20, 2024
IBCN 2024: Keynote Lecture: Inferring Tumor Evolution from Single-Cell Data
September 20, 2024
IBCN 2024: Elucidating the Response Rates to Additional BCG: Implications for Clinical Trial Design
September 20, 2024
ESMO 2024: Scientific Congress Highlights: Genitourinary Tumors, Prostate
September 17, 2024
ESMO 2024: Controversies in Testis Cancer: Escalation or De-escalation?
September 17, 2024
ESMO 2024: Invited Discussant: JCOG1019, TOMBOLA, and SunRISe-4
September 17, 2024
ESMO 2024: Empowering Bladder Cancer Care Integrating Patient Preferences and Voices
September 17, 2024
ESMO 2024: Histology Subtypes (variants) of Bladder Cancer
September 16, 2024
ESMO 2024: Health-Related Quality of Life from the CheckMate 901 Trial of Nivolumab as First-Line Therapy for Unresectable or Metastatic Urothelial Carcinoma
September 16, 2024